# Impact of Interferon Free Regimens in Patients With Chronic HCV and Successfully Treated HCC

> **NCT02771405** · PHASE3 · COMPLETED · sponsor: **National Hepatology & Tropical Medicine Research Institute** · enrollment: 150 (estimated)

## Conditions studied

- Hepatitis C, Chronic
- Hepatocellular Carcinoma

## Interventions

- **DRUG:** Sofosbuvir
- **DRUG:** Ribavirin
- **DRUG:** Simeprevir
- **DRUG:** daclatasvir
- **DRUG:** Ledipasvir

## Key facts

- **NCT ID:** NCT02771405
- **Lead sponsor:** National Hepatology & Tropical Medicine Research Institute
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03
- **Primary completion:** 2017-12
- **Final completion:** 2018-01
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2026-04-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02771405

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02771405, "Impact of Interferon Free Regimens in Patients With Chronic HCV and Successfully Treated HCC". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT02771405. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*